GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » Deferred Policy Acquisition Costs

Profound Medical (TSX:PRN) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Profound Medical Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Profound Medical Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Executives
Arthur Lee Rosenthal Director
Dr. Arun Menawat Director, Senior Officer
Thomas Michael Tamberrino Senior Officer
Rashed Osman Dewan Senior Officer
Abbey Klair Goodman Senior Officer
Murielle Lortie Director
Cynthia Ann Lavoie Director
Brian Ellacott Director
Aaron Davidson Senior Officer
Guruprit Kour Singh Senior Officer
Ian Heynen Senior Officer